Summary
dl-C-allylglycine inhibited the growth of Rd/3 sarcoma in male rats. The percentage tumor inhibition ranged from about 10–50 in a series of experiments carried out during an 18 month period.
dl-C-allyl-N-acetylglycine and the isomere l- and d-C-allylglycine also exhibited antitumor activity.
Zusammenfassung
dl-C-allylglycin hemmt das Wachstum des Rd/3 Sarkoms in männlichen Ratten. Während einer experimentellen Zeitspanne von 18 Monaten schwankte die prozentuelle Hemmung des Tumorwuchses zwischen 10% und 50%.
dl-C-allyl-N-acetylglycin und die Isomeren l- und d-C-allylglycin hemmen ebenfalls das Tumorwachstum.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alberici,M., Rodriguez de Lores Arnaiz,G., De Robertis,E.: Glutamic acid decarboxylase inhibition and ultrastructural changes by the convulsant drug allylglycine. Biochemical Pharmacology 18, 137 (1969)
Berlinguet,L., Martel,F., Dufour,D.: Essais chimiothérapeutiques sur quelques tumeurs cancéreuses chez le rat. Lavai Médical 27, 3 (1959)
Black,S., Wright,N.G.: Aspartic β-semialdehyde-dehydrogenase and aspartic β-semialdehyde. J. Biol. Chem. 213, 39 (1956)
Neish,W.J.P., Smith,J.A.: Inhibition of Rd/3 rat sarcoma by l-asparaginase alone and in combination with sodium para-aminosalicylate. Z. Krebsforschung 79, 78 (1973)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Neish, W.J.P. Inhibition of Rd/3 rat sarcoma by dl-C-allylglycine. Z. Krebsforsch. 82, 295–300 (1974). https://doi.org/10.1007/BF00285564
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00285564